Asian Shares Mixed As China Briefing Disappoints

RTTNews | 6h 50min ago
Asian Shares Mixed As China Briefing Disappoints

(RTTNews) - Asian stocks ended mixed on Thursday, with Chinese and Hong Kong markets giving up early gains to end sharply lower after China announced supportive measures to prop up the country's troubled property sector, albeit on a small scale.

The measures included expanding a "white list" of housing projects eligible for financing and increasing bank lending for such developments to 4 trillion yuan.

The briefing from China's housing minister lacked substantial new measures, leaving investors skeptical regarding further economic growth ahead of third-quarter GDP data due on Friday.

Gold ticked higher to hover near record levels in Asian trading even as speculation about a second Trump presidency and its potential inflationary effects contributed to a stronger dollar.

The euro touched an 11-week low ahead of an expected rate cut by the European Central Bank.

Oil slipped in choppy trading, extending declines for a fifth day on China demand concerns and worries over a global glut.

China's Shanghai Composite index fell 1.05 percent to 3,169.38 as the housing policy briefing failed to impress markets.

Hong Kong's Hang Seng dropped 1.02 percent to 20,079.10 as property developers slumped on investor disappointment.

Japanese markets fell notably as data showed exports dropped for the first time in 10 months in September. The Nikkei average dipped 0.69 percent to 38,911.19 while the broader Topix index settled 0.11 percent lower at 2,687.83.

Tech stocks extended their losses from Wednesday, with Tokyo Electron tumbling 3.2 percent.

Seoul stocks ended little changed after a choppy session. The Kospi average finished marginally lower at 2,609.30 as foreign investors extended their selling streak to a second session.

Top automaker Hyundai Motor slumped 4.7 percent and its smaller affiliate Kia Corp shed 2.7 percent.

Australian markets rallied to record levels after the unemployment rate came in at 4.1 percent in September, slightly below the market consensus of 4.2 percent.

The benchmark S&P/ASX 200 climbed 0.86 percent to 8,355.90 while the broader All Ordinaries index closed up 0.79 percent at 8,624.10.

Financials topped the gainers list, with the big four banks rising between 1.3 percent and 2.6 percent.

Across the Tasman, New Zealand's benchmark S&P/NZX-50 index jumped 1.01 percent to 12,768.54.

U.S. stocks closed higher overnight after upbeat earnings from Morgan Stanley and United Airlines.

The Dow climbed 0.8 percent to a new record closing high, while the S&P 500 added half a percent and the tech-heavy Nasdaq Composite edged up 0.3 percent.

read more
European Shares Gain Before ECB Verdict

European Shares Gain Before ECB Verdict

European stocks traded higher on Thursday as investors digested a slew of earnings and awaited the European Central Bank's interest-rate decision.
RTTNews | 5h 40min ago
Eurozone Inflation Eases To 1.7% In September

Eurozone Inflation Eases To 1.7% In September

Eurozone inflation eased slightly more than initially estimated in September, raising expectations for a quarter point rate cut by the European Central Bank later today. The harmonized index of consumer prices posted an annual increase of 1.7 percent, which was revised down from 1.8 percent estimated on October 1, final data from Eurostat showed on Thursday.
RTTNews | 5h 42min ago
FTSE 100 Slightly Higher On Rate Cut Bets

FTSE 100 Slightly Higher On Rate Cut Bets

U.K. stocks were slightly higher on Thursday as signs of falling inflation spurred expectations that interest rates could be cut faster than previously thought.
RTTNews | 6h 0min ago
CAC 40 Climbs Ahead Of ECB Rate Decision

CAC 40 Climbs Ahead Of ECB Rate Decision

French stocks advanced on Thursday amid bets that the European Central Bank (ECB) will announce an interest-rate cut later in the day, responding to falling inflation and worsening economic conditions.
RTTNews | 6h 17min ago
Staska Pharma Recalls Ascorbic Acid Solution For Injection

Staska Pharma Recalls Ascorbic Acid Solution For Injection

Staska Pharmaceuticals, Inc. is recalling one lot of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL, 50mL vials to the user level, according to the U.S. Food and Drug Administration. The recall was due to the presence of glass particulates in one lot of vials used in the production of the impacted batch.
RTTNews | 6h 19min ago
DAX Gains On Earnings

DAX Gains On Earnings

German stocks traded higher on Thursday as investors digested a slew of earnings and awaited an interest rate cut by the European Central Bank later in the day.
RTTNews | 6h 33min ago
Expedia Stock Climbs On Report Of Takeover Interest By Uber

Expedia Stock Climbs On Report Of Takeover Interest By Uber

Shares of Expedia Group Inc. gained more than 7 percent in after-hours trading on Wednesday and is currently up above 7 percent in pre-market activity on the Nasdaq after the Financial Times reported that ride-hailing major Uber Technologies Inc. has explored a possible takeover deal for the online travel company. Meanwhile, Uber fell nearly 2.7 percent in the extended trading,...
RTTNews | 6h 36min ago